Navigation Links
Measles Risk in Transplant Patients

People with a compromised immune system who have undergone organ transplantation could be at a high risk of measles if they don’t receive the measles, mumps and rubella vaccine in a timely manner.//

Completion of MMR vaccination in southeast London is among the lowest in the United Kingdom. Just over 60 percent of children aged 2 years received a first dose of the vaccine by March 2003. (Data shows there were 66 cases of measles reported in the second quarter of the year.) In a letter in this week’s issue of The Lancet, researchers describe how two children with kidney transplants developed complications from measles. Both children received a single dose of the MMR vaccine before transplantation, but since they were about 2 years old at the time, they were unable to have a preschool booster dose. The first dose of the vaccine is recommended at about 13 months old. The booster dose is then given between 3 and 5 years old.

Authors of the letter write, "The reappearance of measles in the community poses a severe threat to vulnerable immunocompromised individuals, including recipients of transplants. Without a substantial increase in the uptake of MMR vaccination, difficult challenges lie ahead. Measles is a notoriously infectious disease and will spread easily among those who are non-immune."

Researchers also say the two children in their report did not have typical presentations of measles and they caution researchers to be aware of this. They write, "Immunocompromised individuals may manifest only a non-specific illness without rash, which makes rapid diagnosis difficult and may delay measures to prevent further spread"
'"/>




Page: 1

Related medicine news :

1. Acute Measles Supresses HIV Replication
2. Measles Suppresses AIDS Virus
3. Drop in Worldwide Measles deaths by 40%
4. Measles Break Out In Relief Camps
5. Measles Vaccination Drive Intensified In Quake-Hit Pakistan
6. Measles Breaks Out In Kashmir
7. Measles Outbreak In Bihar Creates Panic
8. Death Due To Measles Plummet By About 50% Following WHO Campaign
9. Measles Resurges Due To Drop In Immunization With MMR
10. Staff Nurses Contract Measles from the Patient
11. Generous Donation by US Helps to Curb the Outbreak of Measles in Fiji
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology: